Release Date: 23/07/09 09:11 Summary: Response to ASX Price and Volume Query Price Sensitive: Yes Download Document 64.56KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%